Scientific Sessions

Infections play a significant role in women's reproductive health, with prevention and early detection being key to reducing complications. Sexually transmitted infections (STIs), including chlamydia, gonorrhea, and syphilis, require routine screening and timely treatment to prevent infertility and other long-term consequences. HIV remains a critical concern, impacting pregnancy outcomes and necessitating specialized care to reduce maternal-to-child transmission. Vaginal infections, such as bacterial vaginosis and recurrent urinary tract infections (UTIs), often stem from imbalances in the vaginal microbiome and require targeted antimicrobial or probiotic therapies for effective management.

Maternal-fetal transmission of infections, including cytomegalovirus, toxoplasmosis, and Group B streptococcus, underscores the importance of prenatal screening and preventive interventions. The growing issue of antimicrobial resistance poses a challenge in treating common infections, necessitating judicious antibiotic use and the development of alternative therapies. Pelvic inflammatory disease (PID), often resulting from untreated STIs, can lead to chronic pelvic pain, tubal damage, and infertility, highlighting the need for early diagnosis and comprehensive treatment. Advances in infectious disease management continue to improve maternal and reproductive health outcomes, ensuring safer pregnancies and overall well-being.

• Prevention, Diagnosis, and Management of Sexually Transmitted Infections (STIs)
• HIV and Its Impact on Women's Reproductive Health
• Vaginal Infections and Recurrent Urinary Tract Infections (UTIs)
• Maternal-Fetal Transmission of Infections and Prevention Strategies
• Antimicrobial Resistance in Women's Healthcare
• Pelvic Inflammatory Disease (PID) and Its Long-Term Consequences